CochLear Price to Book Ratio 2023-2024 | CHEOY
Historical price to book ratio values for CochLear (CHEOY) over the last 10 years. The current price to book ratio for CochLear as of July 23, 2025 is 10.74.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| CochLear Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-07-23 | 103.16 | 0.00 | |
| 2024-06-30 | 109.21 | 0.00 | |
| 2023-12-31 | 99.72 | 0.00 | |
| 2023-06-30 | 74.11 | 0.00 | |
| 2022-06-30 | 65.48 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.060B | $1.488B |
| Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.913B | 25.22 |
| CVS Health (CVS) | United States | $77.267B | 9.60 |
| Elevance Health (ELV) | United States | $63.437B | 8.53 |
| Cencora (COR) | United States | $56.784B | 19.75 |
| DiDi Global (DIDIY) | China | $26.545B | 28.20 |
| Labcorp Holdings (LH) | United States | $21.098B | 17.11 |
| Natera (NTRA) | United States | $19.106B | 0.00 |
| BioMerieux (BMXMF) | France | $15.985B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.371B | 0.00 |
| Medpace Holdings (MEDP) | United States | $13.731B | 35.52 |
| ICON (ICLR) | Ireland | $13.042B | 12.12 |
| Solventum (SOLV) | United States | $12.616B | 13.35 |
| Revvity (RVTY) | United States | $11.331B | 19.50 |
| Viatris (VTRS) | United States | $10.845B | 3.73 |
| Sonic Healthcare (SKHHY) | Australia | $8.965B | 0.00 |
| Avantor (AVTR) | United States | $8.872B | 12.89 |
| HealthEquity (HQY) | United States | $8.424B | 36.90 |
| Charles River Laboratories (CRL) | United States | $8.024B | 15.72 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.706B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.059B | 29.79 |
| BrightSpring Health Services (BTSG) | United States | $3.542B | 32.50 |
| Sotera Health (SHC) | United States | $3.225B | 18.32 |
| Surgery Partners (SGRY) | United States | $2.827B | 36.77 |
| Organon (OGN) | United States | $2.553B | 2.71 |
| Concentras Parent (CON) | United States | $2.534B | 14.64 |
| Alignment Healthcare (ALHC) | United States | $2.441B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.308B | 88.90 |
| Progyny (PGNY) | United States | $1.970B | 43.36 |
| GoodRx Holdings (GDRX) | United States | $1.757B | 35.14 |
| PACS (PACS) | United States | $1.750B | 0.00 |
| Premier (PINC) | United States | $1.738B | 13.19 |
| Ardent Health (ARDT) | United States | $1.503B | 6.41 |
| Teladoc Health (TDOC) | United States | $1.477B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.257B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.094B | 8.33 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.902B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 290.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.763B | 7.14 |
| CareDx (CDNA) | United States | $0.725B | 11.32 |
| Embecta (EMBC) | United States | $0.625B | 4.21 |
| Nutex Health (NUTX) | United States | $0.556B | 8.41 |
| So-Young (SY) | China | $0.541B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.524B | 0.00 |
| SBC Medicals (SBC) | United States | $0.516B | 0.00 |
| Omada Health (OMDA) | $0.495B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.62 |
| LifeMD (LFMD) | United States | $0.471B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.414B | 0.00 |
| Enhabit (EHAB) | United States | $0.342B | 28.17 |
| Oncology Institute (TOI) | United States | $0.316B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.287B | 0.00 |
| Beauty Health (SKIN) | United States | $0.231B | 0.00 |
| DocGo (DCGO) | United States | $0.149B | 24.33 |
| Pheton Holdings (PTHL) | China | $0.148B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.109B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| KindlyMD (NAKA) | United States | $0.067B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.053B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.051B | 0.00 |
| ModivCare (MODV) | United States | $0.046B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.016B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |